Keyin Zheng

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Keyin

Contact Keyin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Articles

The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events

Jul 29, 2025 |

By Anqi Lin, Aimin Jiang, XuFeng Huang, Keyin Zheng

| buff.ly

1 Introduction ICIs, representing a revolutionary breakthrough in cancer immunotherapy, restore T-cell antitumor activity by targeting and blocking inhibitory immune molecules, thereby significantly extending the survival of patients with various solid tumors [1-7].

Open in Who Shared

See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Get in touch with Keyin

Contact Keyin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Overview

Use Cases

Capabilities

Industries

Library

Commmunity

Customers

Keyin Zheng

Get in touch with Keyin

Actions

Is this you?

Articles

The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events

Actions

Is this you?

Get in touch with Keyin